Pasithea Therapeutics (KTTA)

• Market cap: $18.4M
• 1 day: 1.91%
• 5 days: -0.98%
• 1 month: -0.38%
• 3 months: -32.46%
• 6 months: 9.24%
• Year to date: -33.03%
• 1 year: -32.46%
• 5 years: -98.88%
• 10 years: -98.88%
• Sector: Healthcare
• Industry: Biotechnology

About: Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

Employees: 4